Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peer Christiansen"'
Autor:
Søren Feddersen, Cathrine Bredal Lythjohan, Thomas P. Ahern, Deirdre Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Timothy L. Lash, Bent Ejlertsen, Per Damkier, Stephen Hamilton-Dutoit
Publikováno v:
Ahern, T P, Damkier, P, Feddersen, S, Kjærsgaard, A, Lash, T L, Hamilton-Dutoit, S, Lythjohan, C B, Ejlertsen, B, Christiansen, P M & Cronin-Fenton, D P 2020, ' Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin ', Acta Oncologica, vol. 59, no. 9, pp. 1009-1015 . https://doi.org/10.1080/0284186X.2020.1759820
Acta Oncol
Acta Oncol
Background: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599fe9f231f4b44d03ae47875a0159e
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Erik Morre Pedersen, Kim Sivesgaard, Thomas Winther Buus, Peer Christiansen, Anders Bonde Jensen, Tanja Linde Fris
Publikováno v:
Buus, T W, Sivesgaard, K, Fris, T L, Christiansen, P M, Jensen, A B & Pedersen, E M 2020, ' Fat fractions from high-resolution 3D radial Dixon MRI for predicting metastatic axillary lymph nodes in breast cancer patients ', European journal of radiology open, vol. 7, 100284 . https://doi.org/10.1016/j.ejro.2020.100284
European Journal of Radiology Open, Vol 7, Iss, Pp 100284-(2020)
European Journal of Radiology Open
European Journal of Radiology Open, Vol 7, Iss, Pp 100284-(2020)
European Journal of Radiology Open
Highlights • High-Resolution 3D radial Dixon MRI allows for the creation of quantitative fat fraction images. • Lymph node fat fractions improves diagnostic performance of MRI to detect axillary lymph node metastases. • Lymph node fat fractions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8a170d7b907b7eee2f53f020254357
https://pure.au.dk/portal/da/publications/fat-fractions-from-highresolution-3d-radial-dixon-mri-for-predicting-metastatic-axillary-lymph-nodes-in-breast-cancer-patients(a59e89fc-97aa-439d-a770-7c56e4665706).html
https://pure.au.dk/portal/da/publications/fat-fractions-from-highresolution-3d-radial-dixon-mri-for-predicting-metastatic-axillary-lymph-nodes-in-breast-cancer-patients(a59e89fc-97aa-439d-a770-7c56e4665706).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast